Pre-emptive pharmacogenetic (PGx) testing using a multiple gene panel to guide treatment and reduce adverse drug reactions
Topic Status Complete
Pharmacogenetics (also referred to as pharmacogenomics; PGx) is the study of how a person's genes affect their response to medications. Differences in genes may result in a particular medicine being effective for some people, but not others. Equally, it may be the reason that some people experience side effects (or adverse reactions) to a medicine, whilst others do not.
Summary
Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of pre-emptive testing using a PGx panel to guide treatment and reduce adverse drug reactions.
The HTW Assessment Group decided not to progress this topic further due to the lack of evidence of effectiveness at present.
Topic Exploration Report
TER465 09.2023
Access our guidance
Our advice documents are free to download, but we would be grateful if you could help us improve our services by telling us why you are looking at our advice and how you intend to use it.
